Supernus Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SUPN and other ETFs, options, and stocks.

About SUPN

Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. 

CEO
Jack A. Khattar
CEOJack A. Khattar
Employees
778
Employees778
Headquarters
Rockville, Maryland
HeadquartersRockville, Maryland
Founded
2005
Founded2005
Employees
778
Employees778

SUPN Key Statistics

Market cap
2.77B
Market cap2.77B
Price-Earnings ratio
-24.43
Price-Earnings ratio-24.43
Dividend yield
Dividend yield
Average volume
1.44M
Average volume1.44M
High today
$47.88
High today$47.88
Low today
$46.43
Low today$46.43
Open price
$47.00
Open price$47.00
Volume
326.51K
Volume326.51K
52 Week high
$59.68
52 Week high$59.68
52 Week low
$40.26
52 Week low$40.26

Stock Snapshot

With a market cap of 2.77B, Supernus Pharmaceuticals(SUPN) trades at $46.89. The stock has a price-to-earnings ratio of -24.43.

On 2026-08-07, Supernus Pharmaceuticals(SUPN) stock traded between a low of $46.43 and a high of $47.88. Shares are currently priced at $46.89, which is +1.0% above the low and -2.1% below the high.

The Supernus Pharmaceuticals(SUPN)'s current trading volume is 326.51K, compared to an average daily volume of 1.44M.

During the past year, Supernus Pharmaceuticals(SUPN) stock moved between $40.26 at its lowest and $59.68 at its peak.

During the past year, Supernus Pharmaceuticals(SUPN) stock moved between $40.26 at its lowest and $59.68 at its peak.

SUPN News

Simply Wall St 1d
Supernus Pharmaceuticals Jumps On Merger Terms, Is The Stock Still Cheap? - simplywall.st

...

Supernus Pharmaceuticals Jumps On Merger Terms, Is The Stock Still Cheap? - simplywall.st
Simply Wall St 4d
Supernus Pharmaceuticals Stock Rebounds As Revenue Growth Meets Profit Crunch

Supernus Pharmaceuticals stock climbed about 3% to roughly US$46, even as the company reported another quarterly loss. The headline this quarter is not the reve...

Supernus Pharmaceuticals Stock Rebounds As Revenue Growth Meets Profit Crunch
TipRanks 4d
Supernus, Indivior Launch Communications on Proposed Merger

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

More SUPN News

Benzinga 4d
Supernus to Combine with Indivior To Form CNS Biopharmaceutical Leader with Potential $2 Billion in Revenue

The combined business will operate as Supernus and trade on the Nasdaq Global Market under the ticker symbol “SUPN.” The companies expect to close the merger d...

Supernus to Combine with Indivior To Form CNS Biopharmaceutical Leader with Potential $2 Billion in Revenue
Nasdaq 4d
Supernus, Indivior Merger Creates $2.2 Bln CNS Company; Shares Surge In Pre-market

(RTTNews) - Supernus Pharmaceuticals, Inc. (SUPN) on Monday entered into a definitive agreement to merge with Indivior Pharmaceuticals, Inc. (INDV) in an all-st...

Supernus, Indivior Merger Creates $2.2 Bln CNS Company; Shares Surge In Pre-market
TipRanks 4d
Supernus reports Q2 EPS ($1.01) with items vs. 40c last year

Reports Q2 revenue $219.1M, consensus $205.43M. Q2 operating loss was $58.0M vs. an operating earnings of $12.1 for the same period in 2025. The change was prim...

TipRanks 4d
Supernus and Indivior announce merger

Supernus Pharmaceuticals (SUPN) and Indivior (INDV) Pharmaceuticals (Nasdaq: INDV) entered into a definitive agreement to combine in a tax-free all-stock merger...

People also own

Based on the portfolios of people who own SUPN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.